Global Transdermal Testosterone Market Growth 2025-2031

October 2025 | 96 pages | ID: G6132D7A4845EN
LP Information

Abstracts

The global Transdermal Testosterone market size is predicted to grow from US$ 670 million in 2025 to US$ 1044 million in 2031; it is expected to grow at a CAGR of 7.7% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Transdermal Testosterone contains testosterone. It is used for hormone replacement in men who are not able to produce enough testosterone (e.g., hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels.

United States market for Transdermal Testosterone is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Transdermal Testosterone is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Transdermal Testosterone is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Transdermal Testosterone players cover AbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Transdermal Testosterone Industry Forecast? looks at past sales and reviews total world Transdermal Testosterone sales in 2024, providing a comprehensive analysis by region and market sector of projected Transdermal Testosterone sales for 2025 through 2031. With Transdermal Testosterone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transdermal Testosterone industry.

This Insight Report provides a comprehensive analysis of the global Transdermal Testosterone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transdermal Testosterone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Transdermal Testosterone market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transdermal Testosterone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transdermal Testosterone.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Testosterone market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Gel
• Patch

Segmentation by Application:

• Primary Hypogonadism
• Hypogonadotropic Hypogonadism
• Late-Onset Hypogonadism

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• AbbVie
• Teva
• Perrigo
• Endo Pharmaceuticals
• Acerus Pharmaceuticals
• Lupin
• Dr. Reddy's Laboratories
• Upsher-Smith Laboratories
• Allergan
• Cipla Inc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Transdermal Testosterone market?
What factors are driving Transdermal Testosterone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Transdermal Testosterone market opportunities vary by end market size?
How does Transdermal Testosterone break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Transdermal Testosterone Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Transdermal Testosterone by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Transdermal Testosterone by Country/Region, 2020, 2024 & 2031
2.2 Transdermal Testosterone Segment by Type
  2.2.1 Gel
  2.2.2 Patch
2.3 Transdermal Testosterone Sales by Type
  2.3.1 Global Transdermal Testosterone Sales Market Share by Type (2020-2025)
  2.3.2 Global Transdermal Testosterone Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Transdermal Testosterone Sale Price by Type (2020-2025)
2.4 Transdermal Testosterone Segment by Application
  2.4.1 Primary Hypogonadism
  2.4.2 Hypogonadotropic Hypogonadism
  2.4.3 Late-Onset Hypogonadism
2.5 Transdermal Testosterone Sales by Application
  2.5.1 Global Transdermal Testosterone Sale Market Share by Application (2020-2025)
  2.5.2 Global Transdermal Testosterone Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Transdermal Testosterone Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Transdermal Testosterone Breakdown Data by Company
  3.1.1 Global Transdermal Testosterone Annual Sales by Company (2020-2025)
  3.1.2 Global Transdermal Testosterone Sales Market Share by Company (2020-2025)
3.2 Global Transdermal Testosterone Annual Revenue by Company (2020-2025)
  3.2.1 Global Transdermal Testosterone Revenue by Company (2020-2025)
  3.2.2 Global Transdermal Testosterone Revenue Market Share by Company (2020-2025)
3.3 Global Transdermal Testosterone Sale Price by Company
3.4 Key Manufacturers Transdermal Testosterone Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Transdermal Testosterone Product Location Distribution
  3.4.2 Players Transdermal Testosterone Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR TRANSDERMAL TESTOSTERONE BY GEOGRAPHIC REGION

4.1 World Historic Transdermal Testosterone Market Size by Geographic Region (2020-2025)
  4.1.1 Global Transdermal Testosterone Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Transdermal Testosterone Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Transdermal Testosterone Market Size by Country/Region (2020-2025)
  4.2.1 Global Transdermal Testosterone Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Transdermal Testosterone Annual Revenue by Country/Region (2020-2025)
4.3 Americas Transdermal Testosterone Sales Growth
4.4 APAC Transdermal Testosterone Sales Growth
4.5 Europe Transdermal Testosterone Sales Growth
4.6 Middle East & Africa Transdermal Testosterone Sales Growth

5 AMERICAS

5.1 Americas Transdermal Testosterone Sales by Country
  5.1.1 Americas Transdermal Testosterone Sales by Country (2020-2025)
  5.1.2 Americas Transdermal Testosterone Revenue by Country (2020-2025)
5.2 Americas Transdermal Testosterone Sales by Type (2020-2025)
5.3 Americas Transdermal Testosterone Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Transdermal Testosterone Sales by Region
  6.1.1 APAC Transdermal Testosterone Sales by Region (2020-2025)
  6.1.2 APAC Transdermal Testosterone Revenue by Region (2020-2025)
6.2 APAC Transdermal Testosterone Sales by Type (2020-2025)
6.3 APAC Transdermal Testosterone Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Transdermal Testosterone by Country
  7.1.1 Europe Transdermal Testosterone Sales by Country (2020-2025)
  7.1.2 Europe Transdermal Testosterone Revenue by Country (2020-2025)
7.2 Europe Transdermal Testosterone Sales by Type (2020-2025)
7.3 Europe Transdermal Testosterone Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Transdermal Testosterone by Country
  8.1.1 Middle East & Africa Transdermal Testosterone Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Transdermal Testosterone Revenue by Country (2020-2025)
8.2 Middle East & Africa Transdermal Testosterone Sales by Type (2020-2025)
8.3 Middle East & Africa Transdermal Testosterone Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transdermal Testosterone
10.3 Manufacturing Process Analysis of Transdermal Testosterone
10.4 Industry Chain Structure of Transdermal Testosterone

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Transdermal Testosterone Distributors
11.3 Transdermal Testosterone Customer

12 WORLD FORECAST REVIEW FOR TRANSDERMAL TESTOSTERONE BY GEOGRAPHIC REGION

12.1 Global Transdermal Testosterone Market Size Forecast by Region
  12.1.1 Global Transdermal Testosterone Forecast by Region (2026-2031)
  12.1.2 Global Transdermal Testosterone Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Transdermal Testosterone Forecast by Type (2026-2031)
12.7 Global Transdermal Testosterone Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 AbbVie
  13.1.1 AbbVie Company Information
  13.1.2 AbbVie Transdermal Testosterone Product Portfolios and Specifications
  13.1.3 AbbVie Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 AbbVie Main Business Overview
  13.1.5 AbbVie Latest Developments
13.2 Teva
  13.2.1 Teva Company Information
  13.2.2 Teva Transdermal Testosterone Product Portfolios and Specifications
  13.2.3 Teva Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Teva Main Business Overview
  13.2.5 Teva Latest Developments
13.3 Perrigo
  13.3.1 Perrigo Company Information
  13.3.2 Perrigo Transdermal Testosterone Product Portfolios and Specifications
  13.3.3 Perrigo Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Perrigo Main Business Overview
  13.3.5 Perrigo Latest Developments
13.4 Endo Pharmaceuticals
  13.4.1 Endo Pharmaceuticals Company Information
  13.4.2 Endo Pharmaceuticals Transdermal Testosterone Product Portfolios and Specifications
  13.4.3 Endo Pharmaceuticals Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Endo Pharmaceuticals Main Business Overview
  13.4.5 Endo Pharmaceuticals Latest Developments
13.5 Acerus Pharmaceuticals
  13.5.1 Acerus Pharmaceuticals Company Information
  13.5.2 Acerus Pharmaceuticals Transdermal Testosterone Product Portfolios and Specifications
  13.5.3 Acerus Pharmaceuticals Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Acerus Pharmaceuticals Main Business Overview
  13.5.5 Acerus Pharmaceuticals Latest Developments
13.6 Lupin
  13.6.1 Lupin Company Information
  13.6.2 Lupin Transdermal Testosterone Product Portfolios and Specifications
  13.6.3 Lupin Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Lupin Main Business Overview
  13.6.5 Lupin Latest Developments
13.7 Dr. Reddy's Laboratories
  13.7.1 Dr. Reddy's Laboratories Company Information
  13.7.2 Dr. Reddy's Laboratories Transdermal Testosterone Product Portfolios and Specifications
  13.7.3 Dr. Reddy's Laboratories Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Dr. Reddy's Laboratories Main Business Overview
  13.7.5 Dr. Reddy's Laboratories Latest Developments
13.8 Upsher-Smith Laboratories
  13.8.1 Upsher-Smith Laboratories Company Information
  13.8.2 Upsher-Smith Laboratories Transdermal Testosterone Product Portfolios and Specifications
  13.8.3 Upsher-Smith Laboratories Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Upsher-Smith Laboratories Main Business Overview
  13.8.5 Upsher-Smith Laboratories Latest Developments
13.9 Allergan
  13.9.1 Allergan Company Information
  13.9.2 Allergan Transdermal Testosterone Product Portfolios and Specifications
  13.9.3 Allergan Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Allergan Main Business Overview
  13.9.5 Allergan Latest Developments
13.10 Cipla Inc.
  13.10.1 Cipla Inc. Company Information
  13.10.2 Cipla Inc. Transdermal Testosterone Product Portfolios and Specifications
  13.10.3 Cipla Inc. Transdermal Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Cipla Inc. Main Business Overview
  13.10.5 Cipla Inc. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Transdermal Testosterone Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Transdermal Testosterone Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Gel
Table 4. Major Players of Patch
Table 5. Global Transdermal Testosterone Sales by Type (2020-2025) & (K Units)
Table 6. Global Transdermal Testosterone Sales Market Share by Type (2020-2025)
Table 7. Global Transdermal Testosterone Revenue by Type (2020-2025) & ($ million)
Table 8. Global Transdermal Testosterone Revenue Market Share by Type (2020-2025)
Table 9. Global Transdermal Testosterone Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Transdermal Testosterone Sale by Application (2020-2025) & (K Units)
Table 11. Global Transdermal Testosterone Sale Market Share by Application (2020-2025)
Table 12. Global Transdermal Testosterone Revenue by Application (2020-2025) & ($ million)
Table 13. Global Transdermal Testosterone Revenue Market Share by Application (2020-2025)
Table 14. Global Transdermal Testosterone Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Transdermal Testosterone Sales by Company (2020-2025) & (K Units)
Table 16. Global Transdermal Testosterone Sales Market Share by Company (2020-2025)
Table 17. Global Transdermal Testosterone Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Transdermal Testosterone Revenue Market Share by Company (2020-2025)
Table 19. Global Transdermal Testosterone Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Transdermal Testosterone Producing Area Distribution and Sales Area
Table 21. Players Transdermal Testosterone Products Offered
Table 22. Transdermal Testosterone Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Transdermal Testosterone Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Transdermal Testosterone Sales Market Share Geographic Region (2020-2025)
Table 27. Global Transdermal Testosterone Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Transdermal Testosterone Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Transdermal Testosterone Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Transdermal Testosterone Sales Market Share by Country/Region (2020-2025)
Table 31. Global Transdermal Testosterone Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Transdermal Testosterone Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Transdermal Testosterone Sales by Country (2020-2025) & (K Units)
Table 34. Americas Transdermal Testosterone Sales Market Share by Country (2020-2025)
Table 35. Americas Transdermal Testosterone Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Transdermal Testosterone Sales by Type (2020-2025) & (K Units)
Table 37. Americas Transdermal Testosterone Sales by Application (2020-2025) & (K Units)
Table 38. APAC Transdermal Testosterone Sales by Region (2020-2025) & (K Units)
Table 39. APAC Transdermal Testosterone Sales Market Share by Region (2020-2025)
Table 40. APAC Transdermal Testosterone Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Transdermal Testosterone Sales by Type (2020-2025) & (K Units)
Table 42. APAC Transdermal Testosterone Sales by Application (2020-2025) & (K Units)
Table 43. Europe Transdermal Testosterone Sales by Country (2020-2025) & (K Units)
Table 44. Europe Transdermal Testosterone Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Transdermal Testosterone Sales by Type (2020-2025) & (K Units)
Table 46. Europe Transdermal Testosterone Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Transdermal Testosterone Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Transdermal Testosterone Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Transdermal Testosterone Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Transdermal Testosterone Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Transdermal Testosterone
Table 52. Key Market Challenges & Risks of Transdermal Testosterone
Table 53. Key Industry Trends of Transdermal Testosterone
Table 54. Transdermal Testosterone Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Transdermal Testosterone Distributors List
Table 57. Transdermal Testosterone Customer List
Table 58. Global Transdermal Testosterone Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Transdermal Testosterone Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Transdermal Testosterone Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Transdermal Testosterone Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Transdermal Testosterone Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Transdermal Testosterone Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Transdermal Testosterone Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Transdermal Testosterone Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Transdermal Testosterone Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Transdermal Testosterone Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Transdermal Testosterone Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Transdermal Testosterone Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Transdermal Testosterone Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Transdermal Testosterone Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. AbbVie Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors
Table 73. AbbVie Transdermal Testosterone Product Portfolios and Specifications
Table 74. AbbVie Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. AbbVie Main Business
Table 76. AbbVie Latest Developments
Table 77. Teva Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors
Table 78. Teva Transdermal Testosterone Product Portfolios and Specifications
Table 79. Teva Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Teva Main Business
Table 81. Teva Latest Developments
Table 82. Perrigo Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors
Table 83. Perrigo Transdermal Testosterone Product Portfolios and Specifications
Table 84. Perrigo Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Perrigo Main Business
Table 86. Perrigo Latest Developments
Table 87. Endo Pharmaceuticals Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors
Table 88. Endo Pharmaceuticals Transdermal Testosterone Product Portfolios and Specifications
Table 89. Endo Pharmaceuticals Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Endo Pharmaceuticals Main Business
Table 91. Endo Pharmaceuticals Latest Developments
Table 92. Acerus Pharmaceuticals Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors
Table 93. Acerus Pharmaceuticals Transdermal Testosterone Product Portfolios and Specifications
Table 94. Acerus Pharmaceuticals Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Acerus Pharmaceuticals Main Business
Table 96. Acerus Pharmaceuticals Latest Developments
Table 97. Lupin Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors
Table 98. Lupin Transdermal Testosterone Product Portfolios and Specifications
Table 99. Lupin Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Lupin Main Business
Table 101. Lupin Latest Developments
Table 102. Dr. Reddy's Laboratories Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors
Table 103. Dr. Reddy's Laboratories Transdermal Testosterone Product Portfolios and Specifications
Table 104. Dr. Reddy's Laboratories Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Dr. Reddy's Laboratories Main Business
Table 106. Dr. Reddy's Laboratories Latest Developments
Table 107. Upsher-Smith Laboratories Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors
Table 108. Upsher-Smith Laboratories Transdermal Testosterone Product Portfolios and Specifications
Table 109. Upsher-Smith Laboratories Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Upsher-Smith Laboratories Main Business
Table 111. Upsher-Smith Laboratories Latest Developments
Table 112. Allergan Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors
Table 113. Allergan Transdermal Testosterone Product Portfolios and Specifications
Table 114. Allergan Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Allergan Main Business
Table 116. Allergan Latest Developments
Table 117. Cipla Inc. Basic Information, Transdermal Testosterone Manufacturing Base, Sales Area and Its Competitors
Table 118. Cipla Inc. Transdermal Testosterone Product Portfolios and Specifications
Table 119. Cipla Inc. Transdermal Testosterone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Cipla Inc. Main Business
Table 121. Cipla Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Transdermal Testosterone
Figure 2. Transdermal Testosterone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transdermal Testosterone Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Transdermal Testosterone Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Transdermal Testosterone Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Transdermal Testosterone Sales Market Share by Country/Region (2024)
Figure 10. Transdermal Testosterone Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Gel
Figure 12. Product Picture of Patch
Figure 13. Global Transdermal Testosterone Sales Market Share by Type in 2025
Figure 14. Global Transdermal Testosterone Revenue Market Share by Type (2020-2025)
Figure 15. Transdermal Testosterone Consumed in Primary Hypogonadism
Figure 16. Global Transdermal Testosterone Market: Primary Hypogonadism (2020-2025) & (K Units)
Figure 17. Transdermal Testosterone Consumed in Hypogonadotropic Hypogonadism
Figure 18. Global Transdermal Testosterone Market: Hypogonadotropic Hypogonadism (2020-2025) & (K Units)
Figure 19. Transdermal Testosterone Consumed in Late-Onset Hypogonadism
Figure 20. Global Transdermal Testosterone Market: Late-Onset Hypogonadism (2020-2025) & (K Units)
Figure 21. Global Transdermal Testosterone Sale Market Share by Application (2024)
Figure 22. Global Transdermal Testosterone Revenue Market Share by Application in 2025
Figure 23. Transdermal Testosterone Sales by Company in 2025 (K Units)
Figure 24. Global Transdermal Testosterone Sales Market Share by Company in 2025
Figure 25. Transdermal Testosterone Revenue by Company in 2025 ($ millions)
Figure 26. Global Transdermal Testosterone Revenue Market Share by Company in 2025
Figure 27. Global Transdermal Testosterone Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Transdermal Testosterone Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Transdermal Testosterone Sales 2020-2025 (K Units)
Figure 30. Americas Transdermal Testosterone Revenue 2020-2025 ($ millions)
Figure 31. APAC Transdermal Testosterone Sales 2020-2025 (K Units)
Figure 32. APAC Transdermal Testosterone Revenue 2020-2025 ($ millions)
Figure 33. Europe Transdermal Testosterone Sales 2020-2025 (K Units)
Figure 34. Europe Transdermal Testosterone Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Transdermal Testosterone Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Transdermal Testosterone Revenue 2020-2025 ($ millions)
Figure 37. Americas Transdermal Testosterone Sales Market Share by Country in 2025
Figure 38. Americas Transdermal Testosterone Revenue Market Share by Country (2020-2025)
Figure 39. Americas Transdermal Testosterone Sales Market Share by Type (2020-2025)
Figure 40. Americas Transdermal Testosterone Sales Market Share by Application (2020-2025)
Figure 41. United States Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Transdermal Testosterone Sales Market Share by Region in 2025
Figure 46. APAC Transdermal Testosterone Revenue Market Share by Region (2020-2025)
Figure 47. APAC Transdermal Testosterone Sales Market Share by Type (2020-2025)
Figure 48. APAC Transdermal Testosterone Sales Market Share by Application (2020-2025)
Figure 49. China Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 53. India Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Transdermal Testosterone Sales Market Share by Country in 2025
Figure 57. Europe Transdermal Testosterone Revenue Market Share by Country (2020-2025)
Figure 58. Europe Transdermal Testosterone Sales Market Share by Type (2020-2025)
Figure 59. Europe Transdermal Testosterone Sales Market Share by Application (2020-2025)
Figure 60. Germany Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 61. France Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Transdermal Testosterone Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Transdermal Testosterone Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Transdermal Testosterone Sales Market Share by Application (2020-2025)
Figure 68. Egypt Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Transdermal Testosterone Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Transdermal Testosterone in 2025
Figure 74. Manufacturing Process Analysis of Transdermal Testosterone
Figure 75. Industry Chain Structure of Transdermal Testosterone
Figure 76. Channels of Distribution
Figure 77. Global Transdermal Testosterone Sales Market Forecast by Region (2026-2031)
Figure 78. Global Transdermal Testosterone Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Transdermal Testosterone Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Transdermal Testosterone Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Transdermal Testosterone Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Transdermal Testosterone Revenue Market Share Forecast by Application (2026-2031)